	Piper Sandler Reaffirms Buy on Amgen Amid MariTide Tolerability Update
	Amgen Insiders Sell US$12m Of Stock, Possibly Signalling Caution
	Amgen says gastric cancer drug meets main goal in late-stage trial
	What’s Happening With Amgen Stock?
	Final Trades: Amgen, Caterpillar, Honeywell and Freeport-McMoran
	Amgen’s obesity drug led to high discontinuation rates in mid-stage trial, as company plans to adjust dosing
	Amgen’s Antibody Improves Overall Survival in Phase III Gastric Cancer Test
	Amgen's Five Prime takeover delivers gastric cancer win